Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DMAC compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
DMAC
DiaMedica Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
DMAC
DiaMedica Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
DMAC
with
LLY
Uncorrelated: r 0.16 · 500D.
No shared co-movers.
DMAC, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
DMAC
DiaMedica Therapeutics Inc.
Change
10.75
▲
+7.46%
· post 10.85
Mkt cap
$539.3M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,419.27
Closed
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 4 '26
DMAC
DiaMedica Therapeutics Inc.
vs
LLY
ELI Lilly & Co
10.75
▲
+7.46%
post 10.85
Price
1,417.89
▲
+0.60%
post 1,419.27
$539.3M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
DMAC
10.75
▲
+7.46%
vs
LLY
1,417.89
▲
+0.60%
Closed
Nov 4 '26